Tolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory authority. The PERSEUS phase 3 study of tolebrutinib in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback